Evidence map›Paper›PMID 40041300›Full record

ArticleImaging neuroscience (Cambridge, Mass.)2024

Thalamic nuclei segmentation from T1-weighted MRI: Unifying and benchmarking state-of-the-art methods.

Brendan Williams, Dan Nguyen, Julie P Vidal, Manojkumar Saranathan

Abstract read
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Thalamic Nuclei Atrophy in Type 1 Diabetes Mellitus Across Disease Duration.Journal of magnetic resonance imaging : JMRI · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Thalamic nuclei insights into Alzheimer's disease.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. A deep learning framework for comprehensive segmentation of deep grey nuclei.medRxiv : the preprint server for health sciences · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Normative modeling of thalamic nuclear volumes.medRxiv : the preprint server for health sciences · 2024
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Brendan WilliamsCentre for Integrative Neuroscience and Neurodynamics, University of Reading, Reading, United Kingdom.
Dan NguyenDepartment of Radiology, University of Massachusetts Chan Medical School, Worcester, MA, United States.
Julie P VidalCNRS, CerCo (Centre de Recherche Cerveau et Cognition) - Université Paul Sabatier, Toulouse, France.
Manojkumar SaranathanDepartment of Radiology, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Next-Generation Thalamic Nuclei Visualization and Segmentation MethodsR01EB032674 · NIBIB · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Manojkumar Saranathan · 2022 to 2026
$1.8M
NIA NIH HHS U01 AG024904NIBIB NIH HHS R01 EB032674
6 · The paper itself

Abstract

The thalamus and its constituent nuclei are critical for a broad range of cognitive, linguistic, and sensorimotor processes, and are implicated in many neurological and neurodegenerative conditions. However, the functional involvement and specificity of thalamic nuclei in human neuroimaging work is underappreciated and not well studied due, in part, to technical challenges of accurately identifying and segmenting nuclei. This challenge is further exacerbated by a lack of common nomenclature for comparing segmentation methods. Here, we use data from healthy young (Human Connectome Project, n = 100) and older healthy adults, plus those with mild cognitive impairment and Alzheimer's disease (Alzheimer's Disease Neuroimaging Initiative, n = 540), to benchmark four state-of-the-art thalamic segmentation methods for T1 MRI (FreeSurfer, histogram-based polynomial synthesis [HIPS]-THOMAS, synthesized contrast segmentation [SCS]-convolutional neural network [CNN], and T1-THOMAS) under a single segmentation framework. Segmentations were compared using overlap and dissimilarity metrics to the Morel stereotaxic atlas, a widely accepted thalamic atlas. We also quantified each method's estimation of thalamic nuclear degeneration across Alzheimer's disease progression, and how accurately early and late mild cognitive impairment, and Alzheimer's disease could be distinguished from healthy controls. We show that the HIPS-THOMAS approach produced the most effective segmentations of individual thalamic nuclei relative to the Morel atlas, and was also most accurate in discriminating healthy controls from those with mild cognitive impairment and Alzheimer's disease using individual nucleus volumes. This latter result was different when using whole thalamus volumes, where the SCS-CNN approach was the most accurate in classifying healthy controls. This work is the first to systematically compare the efficacy of anatomical thalamic segmentation approaches under a unified nomenclature. We also provide recommendations of which segmentation method to use for studying the functional relevance of specific thalamic nuclei, based on their overlap and dissimilarity with the Morel atlas.

Indexed as

Alzheimer’s diseaseFreeSurferhuman connectome projectsegmentationthalamusTHOMAS

Identifiers

PMID40041300
PMCPMC11873765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.